Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. neurol. (Ed. impr.) ; 72(3): 92-102, 1 feb., 2021. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-200677

RESUMO

INTRODUCCIÓN: La epilepsia refractaria al tratamiento médico afecta a entre un tercio y una cuarta parte de los pacientes con epilepsia. Dentro de este grupo, con peor calidad de vida y altos costes sanitarios, existe una considerable proporción de pacientes con causas de epilepsia potencialmente quirúrgicas, y la cirugía de la epilepsia es una opción terapéutica comprobada. En España no sabemos el número real de pacientes que llegan a tratarse en relación con el total de los casos con epilepsia refractaria que podrían beneficiarse del tratamiento quirúrgico. OBJETIVO: Analizar el número de cirugías de epilepsia realizadas y publicadas en relación con los potenciales casos de epilepsia refractaria candidatos a cirugía en nuestro país. MÉTODO: Se realizó una revisión mediante la búsqueda bibliográfica en PubMed y Cochrane de artículos publicados entre 1990 y 2020, combinando las siguientes palabras y operadores booleanos: epilepsy surgery IN Spain’. Se clasificaron las evidencias y recomendaciones según los criterios pronósticos del Oxford Center for Evidence Based Medicine (2001) y de la European Federation of Neurological Societies (2004) para actuaciones terapéuticas. RESULTADOS: El 75,6% de las publicaciones se originó en las comunidades autónomas de Madrid y Cataluña. El 46,4% de los artículos publicados son de series cortas. Contabilizamos 2.113 intervenciones quirúrgicas (resecciones, cirugías paliativas, implantación de electrodos profundos e implantación de neuroestimuladores), lo que representa el 8,7% de la población estimada con epilepsia refractaria. CONCLUSIÓN: La cirugía de la epilepsia en nuestro medio es una indicación terapéutica infrautilizada y que no se ofrece o no se administra a la mayoría de los potenciales beneficiarios


INTRODUCTION: Drug-resistant epilepsy affects between a third and a quarter of patients with epilepsy. Within this group, with a poorer quality of life and high healthcare costs, there is a considerable proportion of patients with potentially surgical causes of epilepsy, and epilepsy surgery is a proven therapeutic option. In Spain, we do not know the actual number of patients who are treated in relation to the total number of cases of refractory epilepsy that could benefit from surgical treatment. AIM: To analyse the number of epilepsy surgical interventions performed and published in relation to the potential cases of refractory epilepsy who are candidates for surgery in our country. METHOD: A review was carried out through a literature search in PubMed and Cochrane of articles published between 1990 and 2020, combining the following words and Boolean operators: epilepsy surgery IN Spain’. The evidence and recommendations were classified according to the prognostic criteria of the Oxford Centre for Evidence Based Medicine (2001) and of Neurological Societies (2004) for therapeutic actions. RESULTS: The majority (75.6%) of the publications came from the autonomous communities of Madrid and Catalonia and 46.4% of the articles published were short series. We counted 2,113 surgical interventions (resections, palliative interventions, implantation of deep electrodes and implantation of neurostimulators), which represents 8.7% of the estimated population with refractory epilepsy. CONCLUSION. Epilepsy surgery in our country is an underused therapeutic indication that is not offered or administered to the majority of potential beneficiaries


Assuntos
Humanos , Epilepsia Resistente a Medicamentos/cirurgia , Procedimentos Neurocirúrgicos/estatística & dados numéricos , Epilepsia Resistente a Medicamentos/epidemiologia , Bibliometria , Espanha/epidemiologia , Prognóstico , Prevalência
2.
Stereotact Funct Neurosurg ; 95(3): 137-141, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28433987

RESUMO

BACKGROUND: Although there are few reports of radiofrequency lesions performed through deep brain stimulation (DBS) electrodes in patients with movement disorders, experience with this method is scarce. METHODS: We present 2 patients who had been previously treated with DBS of subthalamic nuclei (STN) and the ventral intermediate (VIM) nucleus of the thalamus for Parkinson's disease and essential tremor, respectively, and underwent a radiofrequency lesion through their DBS electrodes after developing a hardware infection. The authors conduct a review of the literature regarding this method. RESULTS: Both patients had a good clinical outcome after 20 and 8 months, respectively, as assessed by a reduction in Fahn-Tolosa-Marin Scale and Unified Parkinson's Disease Rating Scale scores. The second patient underwent a second DBS system implantation surgery after his radiofrequency treatment to optimize his management, achieving optimal clinical control with lower current and drug requirements than before the radiofrequency intervention. No adverse effects were observed. CONCLUSIONS: Radiofrequency lesions through DBS electrodes allow the creation of small and localized lesions. Its effectiveness and low-risk profile, in addition to its low cost, make this procedure suitable and a possible alternative in the therapeutic repertoire for the surgical treatment of movement disorders.


Assuntos
Ablação por Cateter , Estimulação Encefálica Profunda , Tremor Essencial/cirurgia , Doença de Parkinson/cirurgia , Núcleo Subtalâmico/cirurgia , Núcleos Ventrais do Tálamo/cirurgia , Idoso , Ablação por Cateter/instrumentação , Estimulação Encefálica Profunda/instrumentação , Eletrodos Implantados , Humanos , Pessoa de Meia-Idade
3.
Neurocir.-Soc. Luso-Esp. Neurocir ; 27(1): 28-32, ene.-feb. 2016. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-150764

RESUMO

Las metástasis intramedulares son entidades infrecuentes relacionadas con el cáncer de pulmón o de mama, siendo excepcional su origen gástrico. Es frecuente que desarrollen clínica más rápidamente que los tumores intramedulares primarios, con déficit motor, dolor, alteraciones esfinterianas, así como trastornos sensitivos de diversa índole, siendo altamente sugestiva la existencia de un síndrome de Brown-Séquard en pacientes con antecedentes oncológicos. El pronóstico de estos pacientes es ominoso, con una supervivencia media aproximada de 4 meses, aunque revisiones recientes postulan que la cirugía puede aportar un leve incremento en la supervivencia, así como una mayor capacidad funcional. Presentamos el caso de un paciente de 61años con una metástasis intramedular cervical de un adenocarcinoma gástrico y revisamos la literatura científica, habiendo 3 casos publicados previamente


Intramedullary spinal cord metastases are very rare and usually associated with lung or breast cancer, with gastric origin being exceptional. Their clinical onset tends to be faster than that of primary intramedullary tumours. The most common early symptoms of intramedullary spinal cord metastasis are motor deficit in one or more limbs, pain, sensory loss, and sphincter disturbances. The appearance of a rapidly progressive Brown-Séquard syndrome in an oncology patient should orientate the diagnosis of this condition. The prognosis is very poor, with a median survival of 4months. However, recent research has shown that surgery could offer a slight benefit in survival and functionality. The case is reported of a 61-year-old man with an intramedullary spinal cord metastasis from a gastric carcinoma, as well as a literature review of this topic. It has been found that this case is the fourth one reported in the literature


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Gástricas/patologia , Neoplasias da Medula Espinal/secundário , Síndrome de Brown-Séquard/patologia , Neoplasias da Medula Espinal/cirurgia , Metástase Neoplásica/patologia , Cervicalgia/etiologia , Espectroscopia de Ressonância Magnética
4.
Neurocirugia (Astur) ; 27(1): 28-32, 2016.
Artigo em Espanhol | MEDLINE | ID: mdl-26589661

RESUMO

Intramedullary spinal cord metastases are very rare and usually associated with lung or breast cancer, with gastric origin being exceptional. Their clinical onset tends to be faster than that of primary intramedullary tumours. The most common early symptoms of intramedullary spinal cord metastasis are motor deficit in one or more limbs, pain, sensory loss, and sphincter disturbances. The appearance of a rapidly progressive Brown-Séquard syndrome in an oncology patient should orientate the diagnosis of this condition. The prognosis is very poor, with a median survival of 4 months. However, recent research has shown that surgery could offer a slight benefit in survival and functionality. The case is reported of a 61-year-old man with an intramedullary spinal cord metastasis from a gastric carcinoma, as well as a literature review of this topic. It has been found that this case is the fourth one reported in the literature.


Assuntos
Adenocarcinoma/secundário , Neoplasias da Medula Espinal/secundário , Neoplasias Gástricas/patologia , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...